LLAI:LSE LungLife AI Inc

GBX 31.00 0.00 0
Icon

LungLife AI Inc (LLAI:LSE) Stock Analysis and Price Targets

COMMON STOCK | Diagnostics & Research | LSE
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

GBX 31.00

0.00 (0.00)%

GBX 0.01B

0.03M

N/A

N/A

Icon

LLAI:LSE

LungLife AI Inc (GBX)
COMMON STOCK | LSE
GBX 31.00
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

GBX 0.01B

N/A

GBX 31.00

LungLife AI Inc (LLAI:LSE) Stock Forecast

N/A

Based on the LungLife AI Inc stock forecast from 0 analysts, the average analyst target price for LungLife AI Inc is not available over the next 12 months. LungLife AI Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of LungLife AI Inc is Bearish, which is based on 2 positive signals and 6 negative signals. At the last closing, LungLife AI Inc’s stock price was GBX 31.00. LungLife AI Inc’s stock price has changed by +5.08% over the past week, -26.19% over the past month and -60.00% over the last year.

No recent analyst target price found for LungLife AI Inc
No recent average analyst rating found for LungLife AI Inc

Company Overview LungLife AI Inc

LungLife AI, Inc., a diagnostic company, researches and develops clinical diagnostic solutions for lung cancer with artificial intelligence (AI) technology in the United States and the People's Republic of China. It engages in developing LungLB, a blood-based test to stratify can...Read More

https://lunglifeai.com

2545 West Hillcrest Drive, Thousand Oaks, CA, United States, 91320

15

December

GBX

UK

Adjusted Closing Price for LungLife AI Inc (LLAI:LSE)

Loading...

Unadjusted Closing Price for LungLife AI Inc (LLAI:LSE)

Loading...

Share Trading Volume for LungLife AI Inc Shares

Loading...

Compare Performance of LungLife AI Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for LLAI:LSE

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To LungLife AI Inc (Sector: Diagnostics & Research )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
IDHC:LSE
Integrated Diagnostics Holding.. +0.03 (+8.69%) GBX0.18B 0.15 0.16

ETFs Containing LLAI

Symbol Name LLAI's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About LungLife AI Inc (LLAI:LSE) Stock

Stock Target Advisor's fundamental analysis for LungLife AI Inc's stock is Bearish.

Unfortunately we do not have enough data on LLAI:LSE's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on LLAI:LSE's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on LLAI:LSE's stock to indicate if its overvalued.

The last closing price of LLAI:LSE's stock was GBX 31.00.

The most recent market capitalization for LLAI:LSE is GBX 0.01B.

Unfortunately we do not have enough analyst data on LLAI:LSE's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains LungLife AI Inc's stock.

As per our most recent records LungLife AI Inc has 15 Employees.

LungLife AI Inc's registered address is 2545 West Hillcrest Drive, Thousand Oaks, CA, United States, 91320. You can get more information about it from LungLife AI Inc's website at https://lunglifeai.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...